Neuroimaging in pre-motor Parkinson's disease

NeuroImage. Clinical
Thomas R BarberMichele Tm Hu

Abstract

The process of neurodegeneration in Parkinson's disease begins long before the onset of clinical motor symptoms, resulting in substantial cell loss by the time a diagnosis can be made. The period between the onset of neurodegeneration and the development of motoric disease would be the ideal time to intervene with disease modifying therapies. This pre-motor phase can last many years, but the lack of a specific clinical phenotype means that objective biomarkers are needed to reliably detect prodromal disease. In recent years, recognition that patients with REM sleep behaviour disorder (RBD) are at particularly high risk of future parkinsonism has enabled the development of large prodromal cohorts in which to investigate novel biomarkers, and neuroimaging has generated some of the most promising results to date. Here we review investigations undertaken in RBD and other pre-clinical cohorts, including modalities that are well established in clinical Parkinson's as well as novel imaging methods. Techniques such as high resolution MRI of the substantia nigra and functional imaging of Parkinsonian brain networks have great potential to facilitate early diagnosis. Further longitudinal studies will establish their true value in quantif...Continue Reading

Citations

Jan 3, 2018·Journal of Neurogastroenterology and Motility·Arun T NairGopalakrishnan Ramalingam
Oct 4, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Roxana G Burciu, David E Vaillancourt
Nov 18, 2018·The European Journal of Neuroscience·Richard Nathaniel ReesAnette Schrag
Mar 29, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B Postuma, Daniela Berg
Aug 15, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Sebastian HeinzelUNKNOWN MDS Task Force on the Definition of Parkinson's Disease
Dec 25, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Katharina A SchindlbeckDavid Eidelberg
Jul 22, 2018·Neural Regeneration Research·Ling LinZhi-Hong Zheng
Aug 7, 2018·F1000Research·Richard Nathaniel ReesAlastair John Noyce
Jul 1, 2020·CNS Neuroscience & Therapeutics·Michael Ugrumov
Sep 15, 2020·Journal of Parkinson's Disease·Chris C TangDavid Eidelberg
Sep 11, 2019·Brain : a Journal of Neurology·Michele T M Hu
May 28, 2020·Frontiers in Neurology·Eldbjørg Hustad, Jan O Aasly
Apr 23, 2020·Parkinson's Disease·Ovidijus LauciusVytautas Danielius
Sep 2, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Dicson Sheeja MalarTewin Tencomnao
Jan 13, 2021·Proceedings of the National Academy of Sciences of the United States of America·Diliana RebeloMiguel Castelo-Branco
Jan 13, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·David J Brooks
Feb 6, 2021·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Michaela KaiserovaPetr Kanovsky
Nov 9, 2020·Journal of the American Academy of Child and Adolescent Psychiatry·Jason J Wolff, Joseph Piven
Apr 22, 2021·Nature Reviews. Neurology·Daniela BergRonald B Postuma
Apr 22, 2021·Brain : a Journal of Neurology·Liche ZhouJun Liu
Feb 10, 2021·Harvard Review of Psychiatry·Alan A Baumeister
May 15, 2021·Biomarkers in Medicine·Lara CheslowScott A Waldman
Jul 10, 2021·Nature Reviews. Neurology·Harald HampelAndrea Vergallo

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
imaging methods

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.